Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY24.77 CNY
Change Today +0.26 / 1.06%
Volume 3.7M
600161 On Other Exchanges
As of 3:05 AM 09/30/15 All times are local (Market data is delayed by at least 15 minutes).

beijing tiantan biological-a (600161) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/8/15 - CNY55.50
52 Week Low
07/8/15 - CNY20.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BEIJING TIANTAN BIOLOGICAL-A (600161)

Related News

No related news articles were found.

beijing tiantan biological-a (600161) Related Businessweek News

No Related Businessweek News Found

beijing tiantan biological-a (600161) Details

Beijing Tiantan Biological Products Co., Ltd. engages in the research, production, and sale of bacterial and viral vaccines, blood products, diagnostic supplies, and other biological products in China. Its products include hepatitis B vaccine, polio vaccine, MMR vaccine, Japanese encephalitis vaccine, influenza vaccine, varicella vaccine, human serum albumin, intravenous human immunoglobulin, and other species. The company is based in Beijing, China.

beijing tiantan biological-a (600161) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing tiantan biological-a (600161) Key Developments

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Aug 21, 2015

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Aug 21, 2015. Agenda: To discuss and approve the text of semi-annual report of 2015 and its abstract; and to consider the proposal of evaluation on remuneration of senior management members in 2014.

Beijing Tiantan Biological Products Corporation Limited Announces Earnings Results for the First Half of 2015

Beijing Tiantan Biological Products Corporation Limited announced earnings results for the first half of 2015. For the period, basic earnings per share were CNY 0.11 and weighted average return on net assets of 2.79%.

Beijing Tiantan Biological Products Co., Ltd. to Report First Half, 2015 Results on Aug 25, 2015

Beijing Tiantan Biological Products Co., Ltd. announced that they will report first half, 2015 results on Aug 25, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600161:CH CNY24.77 CNY +0.26

600161 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hualan Biological Engineering Inc CNY35.11 CNY +0.09
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY29.53 CNY -0.61
Shanghai RAAS Blood Products Co Ltd CNY41.50 CNY +1.34
View Industry Companies

Industry Analysis


Industry Average

Valuation 600161 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING TIANTAN BIOLOGICAL-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at